You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Merck to Allow Generic Manufacturing of Pill That Reportedly Can Cut COVID-19 Deaths by Half

HeadlineOct 28, 2021

The pharmaceutical giant Merck said Wednesday it will share the formula for its COVID-19 therapeutic drug molnupiravir with poor countries, allowing manufacturers to produce cheap, generic versions of the antiviral pill. Merck says the drug can cut the risk of hospitalization or death in half. The People’s Vaccine Alliance applauded the move, tweeting, “It’s positive that unlike the grotesquely unequal distribution of Covid-19 vaccines, poorest countries won’t have to wait at the back of the queue for molnupiravir. BUT middle-income countries shouldn’t still be locked out.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top